371 related articles for article (PubMed ID: 18571912)
1. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis.
Son DJ; Lee HW; Shin HW; Lee JJ; Yoo HS; Kim TJ; Yun YP; Hong JT
Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):383-90. PubMed ID: 18571912
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
González-Díez M; Rodríguez C; Badimon L; Martínez-González J
Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
[TBL] [Abstract][Full Text] [Related]
3. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
[TBL] [Abstract][Full Text] [Related]
4. SKI-II--a sphingosine kinase 1 inhibitor--exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet.
Potì F; Ceglarek U; Burkhardt R; Simoni M; Nofer JR
Atherosclerosis; 2015 May; 240(1):212-5. PubMed ID: 25801013
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate receptors mediate the lipid-induced cAMP accumulation through cyclooxygenase-2/prostaglandin I2 pathway in human coronary artery smooth muscle cells.
Damirin A; Tomura H; Komachi M; Tobo M; Sato K; Mogi C; Nochi H; Tamoto K; Okajima F
Mol Pharmacol; 2005 Apr; 67(4):1177-85. PubMed ID: 15625281
[TBL] [Abstract][Full Text] [Related]
6. Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease.
van der Giet M; Tölle M; Kleuser B
Biol Chem; 2008 Nov; 389(11):1381-90. PubMed ID: 18925828
[TBL] [Abstract][Full Text] [Related]
7. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
Keul P; Tölle M; Lucke S; von Wnuck Lipinski K; Heusch G; Schuchardt M; van der Giet M; Levkau B
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):607-13. PubMed ID: 17158351
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells.
Michaud MD; Robitaille GA; Gratton JP; Richard DE
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):902-8. PubMed ID: 19423865
[TBL] [Abstract][Full Text] [Related]
9. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
Frias MA; James RW; Gerber-Wicht C; Lang U
Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate signaling in the cardiovascular system.
Peters SL; Alewijnse AE
Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 expression is associated with plaque formation in hypercholesterolemic rabbits.
Lin WW; Lin YC; Chang TY; Tsai SH; Ho HC; Chen YT; Yang VC
J Histochem Cytochem; 2006 Aug; 54(8):897-904. PubMed ID: 16585386
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis].
Kimura T; Okajima F; Murakami M
Rinsho Byori; 2007 Apr; 55(4):358-62. PubMed ID: 17511266
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.
Rodríguez C; González-Díez M; Badimon L; Martínez-González J
Thromb Haemost; 2009 Apr; 101(4):665-73. PubMed ID: 19350109
[TBL] [Abstract][Full Text] [Related]
14. Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits.
Hwang SY; Son DJ; Kim IW; Kim DM; Sohn SH; Lee JJ; Kim SK
Phytother Res; 2008 Jun; 22(6):778-83. PubMed ID: 18446850
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-phosphate inhibits migration of RBL-2H3 cells via S1P2: cross-talk between platelets and mast cells.
Yokoo E; Yatomi Y; Takafuta T; Osada M; Okamoto Y; Ozaki Y
J Biochem; 2004 Jun; 135(6):673-81. PubMed ID: 15213242
[TBL] [Abstract][Full Text] [Related]
16. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate.
Dueñas AI; Aceves M; Fernández-Pisonero I; Gómez C; Orduña A; Crespo MS; García-Rodríguez C
Cardiovasc Res; 2008 Aug; 79(3):537-44. PubMed ID: 18411230
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension.
Yogi A; Callera GE; Aranha AB; Antunes TT; Graham D; McBride M; Dominiczak A; Touyz RM
Hypertension; 2011 Apr; 57(4):809-18. PubMed ID: 21383307
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral siRNA silencing of sphingosine-1-phosphate receptors S1P1 and S1P2 in smooth muscle.
Hu W; Huang J; Mahavadi S; Li F; Murthy KS
Biochem Biophys Res Commun; 2006 May; 343(4):1038-44. PubMed ID: 16574065
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate regulates RGS2 and RGS16 mRNA expression in vascular smooth muscle cells.
Hendriks-Balk MC; Hajji N; van Loenen PB; Michel MC; Peters SL; Alewijnse AE
Eur J Pharmacol; 2009 Mar; 606(1-3):25-31. PubMed ID: 19374869
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
